Dec 05, 2019
Check and Point to Side Effects
Uveitis, Cornea/External Disease
1 Self-Assessment AMA PRA Category 1 Credits™
A patient presents with symptoms of progressive, bilateral blurred vision 2 weeks following a second infusion of nivolumab as monotherapy for metastatic, BRAF-positive malignant melanoma. The goal of this case is to improve knowledge of antitumor therapies.